ангиотензин转化酶基因型和沙尔科毒症:与易感性,进展和治疗反应的相关性
Janne Møller1, Ole Hilberg2, Peter Henrik Nissen3
1Aarhus University Hospital, Aarhus, Denmark.
概括
这项研究发现,在丹麦患者中,血管氨酸转化酶 (ACE) 基因型与沙尔科毒症易感性或预后之间没有联系. ACE I/D基因型没有影响疾病结果或治疗反应.
科学领域:
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 关于 ангиотензин转化酶 (ACE) 基因型与沙尔科毒症易感性和预后之间的关联存在相互矛盾的研究.
- 一些研究表明,DD基因型可能会增加沙尔科毒症的风险,并表明预后不佳,而另一些研究发现没有显著影响.
研究的目的:
- 调查ACE基因型对丹麦肺部类菌病患者敏感性,预后和治疗反应的影响.
主要方法:
- 在148名癌症患者的基因型定型中,使用过基因特异性PCR和高分辨率化.
- 将ACE基因型分布与400个健康的丹麦对照进行比较.
- 对ACE基因型与肺功能,放射学分期,Löfgren综合征和24个月治疗反应之间的关联进行分析.
主要成果:
- 在肉病患者中,ACE II,ID和DD基因型的分布分别为25%,52%和23%.
- 在患者和对照组之间没有发现ACE基因型频率的显著差异.
- 预后因素和治疗反应在不同的ACE基因型中没有变化.
结论:
- 这些发现不支持ACE I/D基因型与研究的丹麦队列中的沙尔科毒症易感性之间的联系.
- 在这种人群中,ACE基因型似乎没有影响沙尔科毒症的预后或治疗反应.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
891
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
891
Antihypertensive Drugs: Angiotensin II Receptor Blockers
928
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
928
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
511
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
511
Single Nucleotide Polymorphisms-SNPs
15.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.9K
Genome-wide Association Studies-GWAS
14.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.3K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K


